Clinical Trial Update: QUILT 3.071: NANT Colorectal Cancer (CRC) Vaccine [Phase 1, Phase 2]

View source ↗

Summary

ImmunityBio's QUILT 3.071 NANT colorectal cancer vaccine (Phase 1/2) has been terminated, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer Metastatic

Drugs mentioned

• NANT Colorectal Cancer (CRC) Vaccine

Snippet

Sponsor: ImmunityBio, Inc. | Conditions: Colorectal Cancer Metastatic, mCRC | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2024-12-11